35 research outputs found
Development of a Socially Believable Multi-Robot Solution from Town to Home
Technological advances in the robotic and ICT fields represent an effective solution to address specific societal problems to support ageing and independent life. One of the key factors for these technologies is that they have to be socially acceptable and believable to the end-users. This paper aimed to present some technological aspects that have been faced to develop the Robot-Era system, a multi-robotic system that is able to act in a socially believable way in the environments daily inhabited by humans, such as urban areas, buildings and homes. In particular, this paper focuses on two servicesâshopping delivery and garbage collectionâshowing preliminary results on experiments conducted with 35 elderly people. The analysis adopts an end-user-oriented perspective, considering some of the main attributes of acceptability: usability, attitude, anxiety, trust and quality of life
A Planner for Ambient Assisted Living: From High-Level Reasoning to Low-Level Robot Execution and Back
Robot ecologies are a growing paradigm in which one or several robotic systems are integrated into a smart environment. Robotic ecologies hold great promises for elderly assistance. Planning the activities of these systems, however, is not trivial, and requires consideration of issues like temporal and information dependencies among different parts of the ecology, exogenous actions, and multiple, dynamic goals. We describe a planner able to cope with the above challenges. We show in particular how this planner has been incorporated in closed-loop into a full robotic system that performs daily tasks in support of elderly people. The full robot ecology is deployed in a test apartment inside a real residential building, and it is currently undergoing an extensive user evaluation
Validation of the T-Lymphocyte Subset Index (TLSI) as a Score to Predict Mortality in Unvaccinated Hospitalized COVID-19 Patients
Lymphopenia has been consistently reported as associated with severe coronavirus disease
2019 (COVID-19). Several studies have described a profound decline in all T-cell subtypes in hospitalized patients with severe and critical COVID-19. The aim of this study was to assess the role of
T-lymphocyte subset absolute counts measured at ward admission in predicting 30-day mortality in
COVID-19 hospitalized patients, validating a new prognostic score, the T-Lymphocyte Subset Index
(TLSI, range 0â2), based on the number of T-cell subset (CD4+ and CD8+) absolute counts that are below prespecified cutoffs. These cutoff values derive from a previously published work of our research
group at Policlinico Tor Vergata, Rome, Italy: CD3+CD4+ < 369 cells/”L, CD3+CD8+ < 194 cells/”L.
In the present single-center retrospective study, T-cell subsets were assessed on admission to the
infectious diseases ward. Statistical analysis was performed using JASP (Version 0.16.2. JASP Team,
2022, The Amsterdam, The Netherlands) and Prism8 (version 8.2.1. GraphPad Software, San Diego,
CA, USA). Clinical and laboratory parameters of 296 adult patients hospitalized because of COVID-19
were analyzed. The overall mortality rate was 22.3% (66/296). Survivors (S) had a statistically
significant lower TLSI score compared to non-survivors (NS) (p < 0.001). Patients with increasing
TLSI scores had proportionally higher rates of 30-day mortality (p < 0.0001). In the multivariable
logistic analysis, the TLSI was an independent predictor of in-hospital 30-day mortality (OR: 1.893,
p = 0.003). Survival analysis showed that patients with a TLSI > 0 had an increased risk of death
compared to patients with a TLSI = 0 (hazard ratio: 2.83, p < 0.0001). The TLSI was confirmed as an
early and independent predictor of COVID-19 in-hospital 30-day mortalit
Parietal resting-state EEG alpha source connectivity is associated with subcortical white matter lesions in HIV-positive people
Objective
Parietal resting-state electroencephalographic (rsEEG) alpha (8â10 Hz) source connectivity is abnormal in HIV-positive persons. Here we tested whether this abnormality may be associated with subcortical white matter vascular lesions in the cerebral hemispheres.
Methods
Clinical, rsEEG, and magnetic resonance imaging (MRI) datasets in 38 HIV-positive persons and clinical and rsEEG datasets in 13 healthy controls were analyzed. Radiologists visually evaluated the subcortical white matter hyperintensities from T2-weighted FLAIR MRIs (i.e., Fazekas scale). In parallel, neurophysiologists estimated the eLORETA rsEEG source lagged linear connectivity from parietal cortical regions of interest.
Results
Compared to the HIV participants with no/negligible subcortical white matter hyperintensities, the HIV participants with mild/moderate subcortical white matter hyperintensities showed lower parietal interhemispheric rsEEG alpha lagged linear connectivity. This effect was also observed in HIV-positive persons with unimpaired cognition. This rsEEG marker allowed good discrimination (area under the receiver operating characteristic curve > 0.80) between the HIV-positive individuals with different amounts of subcortical white matter hyperintensities.
Conclusions
The parietal rsEEG alpha source connectivity is associated with subcortical white matter vascular lesions in HIV-positive persons, even without neurocognitive disorders.
Significance
Those MRI-rsEEG markers may be used to screen HIV-positive persons at risk of neurocognitive disorders
DECLINE OF PREVALENCE OF RESISTANCE ASSOCIATED SUBSTITUTIONS TO NS3 AND NS5A INHIBITORS AT DAA- FAILURE IN HEPATITIS C VIRUS IN ITALY OVER THE YEARS 2015 TO 2018
Background: A minority of patients fails to eliminate HCV and resistance-associated substitutions (RASs) are commonly detected at failure of interferon-free DAA regimens . Methods: Within the Italian network VIRONET-C, the prevalence of NS3/NS5A/NS5B RASs was retrospectively evaluated in patients who failed an EASL recommended DAA-regimen in 2015-2018 . The geno2pheno system and Sorbo MC et al. Drug Resistance Updates 2018 were used to infer HCV- genotype/subtype and predict drug resistance . The changes in prevalence of RASs over time were evaluated by chi-square test for trend, predictors of RASs at failure were analysed by logistic regression . Results: We included 386 HCV infected patients: 75% males, median age was 56 years (IQR 52-61), metavir fibrosis stage F4 in 76%; 106 (28%) were treatment- experienced: 91 (86%) with IFN-based treatments, 26 (25%) with DAAs. Patients with HIV and HBV coinfection were 10% (33/317) and 8% (6/72), respectively. HCV genotype was 1b in 122 pts (32%), 3 in 109 (28%), 1a in 97 (25%), 4 in 37 (10%), 2 in 21 (5%). DAA regimens were: LDV/SOF in 115 (30%), DCV/SOF in 103 (27%), 3D in 83 (21%), EBR/GRZ in 32 (8%), VEL/SOF in 29 (7%), GLE/PIB in 18 (5%) and 2D in 6 (2%); ribavirin was administered in 123 (32%) . The NS5A fasta-sequence was available for all patients, NS5B for 361 (94%), NS3 for 365 (95%) . According to the DAA failed the prevalence of any RASs was 90%, namely 80/135 (59%) in NS3, 313/359 (87%) in NS5A, 114/286 (40%) in NS5B . The prevalence of any RASs significantly declined from 2015 to 2018 (93% vs 70%, p=0.004): NS5A RASs from 90% to 72% (p=0 .29), NS3 RASs from 74% to 18% (p<0 .001), while NS5B RASs remained stable . Independent predictors of any RASs included advanced fibrosis (AOR 6.1, CI 95% 1.8-20.3, p=0 .004) and genotype (G2 vs G1a AOR 0 .03, CI 95% 0 .002- 0 .31, p=0 .004; G3 vs G1a AOR 0 .08, CI 95% 0 .01-0 .62, p=0 .02; G4 vs G1a AOR 0 .05, CI 95% 0 .006-0 .46, p=0 .008), after adjusting for age, previous HCV treatment and year of genotype . Notably, full activity was predicted for GLE/PIB in 75% of cases and for at least two components of VEL/SOF/VOX in 53% of cases, no case with full-resistance to either regimen was found . Conclusion: Despite decreasing prevalence over the years, RASs remain common at virological failure of DAA treatment, particularly in patients with the highest grade of liver fibrosis. The identification of RASs after failure could play a crucial role in optimizing retreatment strategies
Predicting needlestick and sharps injuries in nursing students: Development of the SNNIP scale
© 2020 The Authors. Nursing Open published by John Wiley & Sons Ltd. Aim: To develop an instrument to investigate knowledge and predictive factors of needlestick and sharps injuries (NSIs) in nursing students during clinical placements. Design: Instrument development and cross-sectional study for psychometric testing. Methods: A self-administered instrument including demographic data, injury epidemiology and predictive factors of NSIs was developed between October 2018âJanuary 2019. Content validity was assessed by a panel of experts. The instrument's factor structure and discriminant validity were explored using principal components analysis. The STROBE guidelines were followed. Results: Evidence of content validity was found (S-CVI 0.75; I-CVI 0.50â1.00). A three-factor structure was shown by exploratory factor analysis. Of the 238 participants, 39% had been injured at least once, of which 67.3% in the second year. Higher perceptions of âpersonal exposureâ (4.06, SD 3.78) were reported by third-year students. Higher scores for âperceived benefitsâ of preventive behaviours (13.6, SD 1.46) were reported by second-year students
L'evoluzione del diritto commerciale
Il saggio tratteggia l'evoluzione del diritto commerciale dal codice del 1865 ai giorni nostri
Imprese, imprenditori e diritto
Il saggio analizza l'evoluzione del diritto commerciale dal 1865 ai giorni nostr
Marghieri, Alberto
Biografia del giurista Alberto Marghier